secwatch.observer — SEC 8-K summary
======================================

Issuer:     AGILE THERAPEUTICS INC (—)
CIK:        0001261249
Form:       8-K
Filed at:   2023-06-27T23:59:59+00:00
Accession:  0001558370-23-011461
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Agile Therapeutics appoints Scott Coiante as SVP, CFO; CAO Jason Butch to depart
--------------------------------------------------------------------------------

- Scott Coiante appointed SVP, CFO and Treasurer effective Aug 16, 2023; he previously served as Agile's CFO from 2010-2019.
- Jason Butch to separate as Chief Accounting Officer on Aug 15, 2023 by mutual agreement.
- Butch to receive 6 months base salary and health care subsidies as severance, subject to signing release.
- Coiante most recently CFO of Aprea Therapeutics; prior roles at Medarex and Ernst & Young.
- No family relationships or material interests between Coiante and any director or officer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1261249/000155837023011461/0001558370-23-011461-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1261249/000155837023011461/agrx-20230621x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-011461

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer